Day: February 7, 2024

Increasing access to Imaging Mass Cytometry in pharmaceutical and clinical research settings SOUTH SAN FRANCISCO, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced a collaboration agreement with Navignostics AG for development of clinical research applications and service offerings using the Hyperion XTi™ Imaging System. This collaboration is pivotal in the fight against cancer, emphasizing the need for precision medicine strategies and robust technologies that offer critical biological insights to guide treatment decisions. Imaging Mass Cytometry™ is purpose-built to clearly generate and differentiate these insights to help inform clinical outcomes, providing the opportunity...

Almere, the Netherlands February 7, 2024 ASM International N.V. (Euronext Amsterdam: ASM) will report its fourth quarter 2023 financial results at approximately 6:00 p.m. CET on Tuesday, February 27, 2024. ASM will host the quarterly earnings conference call and webcast on Wednesday, February 28, 2024, at 3:00 p.m. CET. Conference-call participants should pre-register using this link to receive the dial-in numbers, passcode and a personal PIN, which are required to access the conference call. A simultaneous audio webcast and replay will be accessible at this link. About ASM International ASM International N.V., headquartered in Almere, the Netherlands, and its subsidiaries design and manufacture equipment and process solutions to produce semiconductor devices for wafer processing, and have facilities in the United States, Europe, and Asia....

VANCOUVER, British Columbia, Feb. 07, 2024 (GLOBE NEWSWIRE) — Rogers Sugar Inc. (RSI) will be holding a conference call to discuss their 2024 first quarter results on Thursday, February 8, 2024, at 8h00 (Eastern Time). The conference call will be chaired by Mr. Michael Walton, Chief Executive Officer and Mr. Jean-Sébastien Couillard, Chief Financial Officer. If you wish to participate, please dial 1-888-886-7786. A recording of the conference call will be accessible shortly after the conference, by dialing 1-877-674-7070, access code 805894#. This recording will be available until April 30, 2024. For further information: Jean-Sébastien CouillardVice President of Finance, Chief Financial Officer and Corporate SecretaryTel./Tél.: (514) 940-4350www.lanticrogers.com

Panostaja Oyj     Stock Exchange Bulletin, Decisions of General Meeting      February 7, 2024 at 4 p.m.Panostaja Oyj’s Annual General Meeting was held on February 7, 2024 in Tampere. The Annual General Meeting adopted the financial statements and consolidated financial statements presented for the financial period November 1, 2022–October 31, 2023 and resolved that no dividends shall be distributed from said financial period. In addition, the Annual General Meeting resolved to authorize the Board to decide, at its discretion, on the potential distribution of assets to shareholders, should the company’s financial status permit this, either as dividends or as repayment of capital from the invested unrestricted equity fund. The maximum distribution of assets performed on the basis of this authorization totals EUR 4,700,000. The authorization...

LEXINGTON, Mass., Feb. 07, 2024 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that the U.S. Department of Health and Human Services (“HHS”) and the Steven & Alexandra Cohen Foundation (“Cohen Foundation”) have selected T2 Biosystems as a Phase 2 winner in the LymeX Diagnostics Prize, a prize competition to accelerate the development of Lyme disease diagnostics. As a Phase 2 winner, T2 Biosystems will receive $265,000. T2 Biosystems’ solution, the T2Lyme™ Panel, is a direct-from-blood molecular diagnostic test designed to run on the FDA-cleared T2Dx® Instrument and to detect Borrelia burgdorferi, the bacteria that causes Lyme disease. The T2Lyme Panel is intended to test individuals with signs and symptoms...

SAN DIEGO, Feb. 07, 2024 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that financial advisor Blair Waller, CFP®, has joined LPL Financial’s broker-dealer, RIA and custodial platforms. He reported having served approximately $150 million in advisory, brokerage and retirement plan assets*, and joins LPL from Corebridge Financial, formerly Valic, a subsidiary of AIG.   With the move, he launches Waller Creek Wealth Management, an independent financial practice based in Austin, Texas. The name of the firm – which is coincidental – is a nod to Waller Creek, a stream that runs through the University of Texas at Austin and is named after the first mayor of the city. Waller, who started in the financial services industry nearly a decade ago, said his goal for the new boutique practice is to cultivate and maintain close relationships...

Consistent with Company’s Zero-Waste Inspired® Mission, Self-Watering In-Store Displays Reduce Waste and Offer Superior Products to ConsumersEdible Garden’s Self-Watering In-Store DisplayEdible Garden’s Self-Watering In-Store DisplayEdible Garden’s Self-Watering In-Store DisplayBELVIDERE, NJ, Feb. 07, 2024 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a patent related to its in-store, Self-Watering Display. The USPTO has issued U.S. Patent No. D1,010,365 S, titled, “Plant Display Apparatus” to Edible Garden AG Incorporated. The patent encompasses methods and systems...